We analyze Medicare Part D's net effect on elderly out-of-pocket (OOP) costs and use of prescription drugs using a dataset containing 1.4 billion prescription records from Wolters Kluwer Health (WKH). These data span the period December 2004-December 2007 and include pharmacy customers whose age...

Using nationwide county-level longitudinal data, we show that recent declines in housing prices are associated with an increased utilitization of antidepressant prescriptions among the near elderly. Our results persist in difference-in-difference models using either all non-antidepressant drugs...

This paper describes three prototypical systems of therapeutic reference pricing (RP) for pharmaceuticals—Germany, the Netherlands, and New Zealand—and examines their effects on the availability of new drugs, reimbursement levels, manufacturer prices, and out-of-pocket surcharges to patients....

"Professional partnerships might facilitate matching between specialized professionals and heterogeneous consumers, particularly where matching across firms is limited by information, incentives or regulation. We examine the extent to which internally-differentiated medical groups promote...